U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
LILOTOMAB
58I6YNR7BV
Investigational
General
Names
6
Identifiers
6
Subunits
4
Related Substances
1
LILOTOMAB
58I6YNR7BV
Investigational
General
Approval Year
Unknown
139,594
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
LILOTOMAB
Official Name
English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD37(TSPAN26, TETRASPANIN-26)), MUS MUSCULUS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-443) (MUS MUSCULUS VH (IGHV1S135*01 (96.90%)-(IGHD)-IGHJ4*01) (8.8.12) (1-119)-IGHG1*01 (CH1 E84>Q (177), P95>T (193), R96
Common Name
English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD37) (MUS MUSCULUS MONOCLONAL HH1 HEAVY CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL HH1 LIGHT CHAIN, DIMER
Common Name
English
lilotomab [INN]
Common Name
English
HH1
Code
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
58I6YNR7BV
PRIMARY
NCI_THESAURUS
C165685
PRIMARY
INN
10071
PRIMARY
WIKIPEDIA
Lilotomab
PRIMARY
CAS
1453362-55-4
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
58I6YNR7BV
LILOTOMAB